Filing Details
- Accession Number:
- 0001144204-13-004838
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-30 16:58:24
- Reporting Period:
- 2013-01-28
- Filing Date:
- 2013-01-30
- Accepted Time:
- 2013-01-30 16:58:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
771856 | Champions Oncology Inc. | CSBR | Biological Products, (No Disgnostic Substances) (2836) | 521401755 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1220630 | Joel Ackerman | C/O Champions Oncology, Inc. One University Place, Suite 307 Hackensack NJ 07601 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-01-28 | 500,000 | $0.50 | 833,333 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-01-28 | 28,315 | $0.00 | 861,648 | No | 4 | J | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | J | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant to purchase shares of Common Stock | Acquisiton | 2013-01-28 | 50,000 | $0.00 | 50,000 | $0.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2013-01-28 | 2018-01-28 | No | 4 | A | Direct |
Footnotes
- As a result of the transaction represented in the line above, the 28,315 shares of Common Stock were issued for no consideration pursuant to contractual anti-dilution undertakings of the Issuer in a Securities Purchase Agreement dated March 24, 2011 between the Issuer, the reporting person and certain other investors.
- The warrant was acquired in connection with the purchase of shares of Common Stock pursuant to a Securities Purchase Agreement dated January 28, 2013 between the Issuer, the reporting person and certain other investors for no additional consideration.